Table V.

Multiple antimicrobial resistance patterns (antibiogram) of isolated bacteria at JMC, Jimma, Southwest Ethiopia, from July 2021 to October 2021

Resistance	Antimicrobial agent	Frequency-number (%)
Resistance to 2 drugs	P, CFO	1 (4.8%)
Resistance to 3 drugs	CTR, CAZ, TET	1 (4.8%)
Resistance to 4 drugs	TET, CRT, SXT, CIP MEM, CN, CAZ, TET CTR, CIP, SXT, CAZ CFO, ERY, TET, CIP CLR, SXT, CAZ, MEM	1 (4.8%) 1 (4.8%) 2 (9.5%) 1 (4.8%) 1 (4.8%)
Resistance to ≥ 5 drugs	AMP, P, CFO, ERY, TET, CIP CTR, CAZ, AMP, AMI, TET, CIP CN, AMI, TET, CIP, MEM, CAZ CN, AMI, TET, CIP, MEM, CAZ TET, CTR, SXT, MEM, CAZ CLR, AMI, TET, CTR,CIP, SXT CN, AMI, TET, CTR, SXT, CAZ CLR, CN, TET, CTR, SXT, CIP, CAZ, MEM CLR, CN, TET, CTR, SXT, CIP, CAZ, MEM, IMI CLR, CN, AMI, TET, CTR, CIP, CAZ, MEM, SXT, IMI CLR, CN, AMI, TET, CTR, SXT, CIP, CAZ, MEM, IMI CLR, CN, TET, CTR, SXT, CIP, CAZ, MEM, SXT, IMI	1 (4.8%) 2 (9.5%) 1 (4.8%) 1 (4.8%) 1 (4.8%) 1 (4.8%) 1 (4.8%) 1 (4.8%) 1 (4.8%) 1 (4.8%) 1 (4.8%) 1 (4.8%)

CLR chloramphenicol, CN gentamicin, AMI amikacin, TET tetracycline, CTR ceftriaxone, CIP ciprofloxacin, SXT sulfamethoxazole-trimethoprim, CAZ ceftazidime, MEM meropenem, IMI imipenem, AMP ampicillin, CFO cefoxitin, ERY erythromycin, P penicillin, CLI clindamycin.